Gyre Therapeutics, Inc. · NASDAQ:GYRE

Ye Weiguo sold 28,680 Gyre Therapeutics, Inc. shares (Form 4)

Traded May 14 to May 15, 2026 · Filed May 18, 2026

From May 14 to May 15, 2026, Ye Weiguo (Chief Operating Officer) sold 28,680 Gyre Therapeutics, Inc. shares at an average US$6.79 for US$195K, leaving 700,000 shares. Filed May 18, 2026 (Form 4).

Sold: 28,680 shares
Price: US$6.79 average (US$6.65 to US$6.91)
Value: US$195K
Holding after: 700,000 shares
Trading plan: No
Role: Chief Operating Officer

The filing in full

Date	Security	Transaction	Shares	Price	Holding after	Ownership
May 14, 2026	Common Stock	Option exercise	15,580	US$0.75	715,580	Direct
May 14, 2026	Common Stock	Sale	15,580	US$6.91	700,000	Direct
May 15, 2026	Common Stock	Option exercise	13,100	US$0.75	713,100	Direct
May 15, 2026	Common Stock	Sale	13,100	US$6.65	700,000	Direct

Source

View original at SEC

Related